Carl W. Porter
About
In The Last Decade
Carl W. Porter
166 papers receiving 7.3k citations
Peers
Comparison fields: 5 of 132
- Molecular Biology 6.3k
- Biochemistry 3.1k
- Pharmacology 1.9k
- Oncology 479
- Organic Chemistry 387
Countries citing papers authored by Carl W. Porter
This map shows the geographic impact of Carl W. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl W. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl W. Porter more than expected).
Fields of papers citing papers by Carl W. Porter
This network shows the impact of papers produced by Carl W. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl W. Porter. The network helps show where Carl W. Porter may publish in the future.
Co-authorship network of co-authors of Carl W. Porter
This figure shows the co-authorship network connecting the top 25 collaborators of Carl W. Porter. A scholar is included among the top collaborators of Carl W. Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl W. Porter. Carl W. Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 314 | |
| 3 | 42 | |
| 4 | 17 | |
| 5 | Apoptotic signaling in polyamine analogue-treated SK-MEL-28 human melanoma cells. | 88 |
| 6 | Spermidine/spermine n(1)-acetyltransferase catalyzes amantadine acetylation. | 17 |
| 7 | 110 | |
| 8 | Lysosomal sequestration of polyamine analogues in Chinese hamster ovary cells resistant to the S-adenosylmethionine decarboxylase inhibitor, CGP-48664. | 11 |
| 9 | Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells. | 47 |
| 10 | Sequence specific antisense oligonucleotide analog interference with spermidine/spermine N1-acetyltransferase gene expression. | 4 |
| 11 | Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action. | 67 |
| 12 | Differential effects of the spermine analog, N1, N12-bis(ethyl)-spermine, on polyamine metabolism and cell growth in human melanoma cell lines and melanocytes. | 47 |
| 13 | Antitumor activity of N,N'-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts. | 85 |
| 14 | 33 | |
| 15 | Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. | 184 |
| 16 | Major increases in spermidine/spermine-N1-acetyltransferase activity by spermine analogues and their relationship to polyamine depletion and growth inhibition in L1210 cells. | 50 |
| 17 | 47 | |
| 18 | Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines. | 40 |
| 19 | Comparative effects of methylglyoxal-bis(guanylhydrazone) (mgbg) on mitochondrial (mt) and nuclear (n) dna of mouse leukemia l1210 cells in culture. Abstr. | 1 |
| 20 | Cell population kinetics of fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse. | 18 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.